NIH-funded research R01 grant

Heterochronic model to understand birth defects in Down syndrome

Official title: A heterochronic model for birth defects in Down Syndrome

Funded at University of Chicago · NIH-11516454 · Data updated 2026-11-12

A study at the University of Chicago will explore how having an extra chromosome 21 affects heart and brain development, aiming to uncover the causes of common birth defects in Down syndrome.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startApril 1, 2026
Project endMarch 31, 2028
Funding year2026
Award (this year)$1,591,945
NIH project number4R01HD111938-02
Project IDNIH-11516454 on NIH RePORTER

Who could benefit from this research

Could help

Children with Down syndrome or families affected by DS who may benefit from future therapies or risk assessment based on mechanistic insights.

Less likely to help

This research is basic science and may not directly change care in the near term for all DS patients.

What this research studies

Researchers will use a heterochronic model to study how trisomy 21 disrupts the timing of heart and brain development. They will examine molecular networks and Hedgehog signaling as a developmental timer that influences organ-specific progenitor cells. The goal is to map how extra chromosome 21 leads to congenital heart defects and intellectual disabilities, using mammalian models to connect gene dosage with organogenesis. Findings could reveal key stages where intervention might prevent or lessen DS-related defects.

Why it matters

Potential benefit: This work could identify critical windows and molecular targets to prevent or lessen heart and brain abnormalities in Down syndrome.

How similar studies have gone: Previous work has connected trisomy 21 to developmental timing and organ defects, with mechanistic insight progressing in model systems.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Moskowitz, Ivan Paul — University of Chicago
  • Study coordinator: Moskowitz, Ivan Paul

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.